Evidence map›Paper›PMID 41490054›Full record

ArticlePloS one2026

Cold plasma-induced transcriptomic reprogramming and alternative splicing in tomato plants infected with ToBRFV.

Mahsa Rostami, Abozar Ghorbani, Davoud Koolivand, Abolfazl Mazandarani

Abstract read
In one paragraph

Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Mahsa RostamiNuclear Agriculture Research School, Nuclear Science and Technology Research Institute (NSTRI), Karaj, Iran.ORCID https://orcid.org/0000-0002-6684-0366
Abozar GhorbaniNuclear Agriculture Research School, Nuclear Science and Technology Research Institute (NSTRI), Karaj, Iran.ORCID https://orcid.org/0000-0002-2183-0033
Davoud KoolivandDepartment of Plant Protection, Faculty of Agriculture, University of Zanjan, Zanjan, Iran.
Abolfazl MazandaraniPlasma and Nuclear Fusion Research School, Nuclear Science and Technology Research Institute, Tehran, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cold atmospheric plasma (CAP), specifically cold air glow discharge plasma (CAGDP), offers a novel approach to enhancing plant defense against viral infections. This study investigates the effects of CAGDP on alternative splicing (AS) and transcriptome-wide gene expression in tomato seedlings infected with Tomato brown rugose fruit virus (ToBRFV). Using high-throughput RNA sequencing and bioinformatics analyses via CLC Genomics Workbench, custom Python scripts, and functional enrichment tools including STRING database and KEGG REST API, we identified significant AS changes, predominantly exon skipping and intron retention, in chromosomes associated with disease resistance. These splicing alterations were linked to key biological processes such as metabolic pathways, catalytic activity, and hormone signaling. Moreover, integration of miRNA-mRNA networks predicted by psRNATarget and visualized in Cytoscape revealed a complex regulatory system involving both transcriptional and post-transcriptional mechanisms. The identification of 19 differentially expressed AS genes highlights the coordinated reprogramming induced by CAGDP to activate antiviral defenses. These findings highlight cold plasma technology as a promising, eco-friendly tool to reprogram plant molecular pathways and enhance resistance to viral pathogens.

Indexed as

Alternative SplicingPlant DiseasesPlasma GasesSolanum lycopersicumTranscriptomeDisease ResistanceGene Expression ProfilingGene Expression Regulation, PlantMicroRNAsMicroRNAsPlasma Gases

Identifiers

PMID41490054
PMCPMC12768285

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.